The UK commenced routine anti-HCV screening using Ortho, Abbott and UBI ELISA tests with confirmatory testing using RIBA II tests in reference laboratories. Read more about The UK commenced routine anti-HCV screening using Ortho, Abbott and UBI ELISA tests with confirmatory testing using RIBA II tests in reference laboratories.
Highlights from the fifth meeting of the Advisory Committee on the Virological Safety of Blood recorded "Agreed not to introduce test in advance of FDA approval but very compelling reasons to implement quickly following U.S. decision." Read more about Highlights from the fifth meeting of the Advisory Committee on the Virological Safety of Blood recorded "Agreed not to introduce test in advance of FDA approval but very compelling reasons to implement quickly following U.S. decision."
Professor Cash wrote to Dr McIntyre at the Scottish Home and Health Department asking him to confirm his agreement that discussions between senior Scottish National Blood Transfusion Service managers and Ortho Ltd regarding use of their anti-HCV test should not take place until instructions were received from the Scottish Home and Health Department. Read more about Professor Cash wrote to Dr McIntyre at the Scottish Home and Health Department asking him to confirm his agreement that discussions between senior Scottish National Blood Transfusion Service managers and Ortho Ltd regarding use of their anti-HCV test should not take place until instructions were received from the Scottish Home and Health Department.
Professor Cash wrote to Dr William Whitrow (Inverness), Dr Stan Urbaniak (Aberdeen) and Dr Ewa Brookes (Dundee) tasking them to let him know of any sera they had which might be of interest for Chiron testing. Read more about Professor Cash wrote to Dr William Whitrow (Inverness), Dr Stan Urbaniak (Aberdeen) and Dr Ewa Brookes (Dundee) tasking them to let him know of any sera they had which might be of interest for Chiron testing.
Professor Cash wrote to Dr Ludlam at the Royal Infirmary Edinburgh saying: "We (SNBTS) hope to have restricted access to the Chiron (NANB) testing kits and I write to enquire whether you would be prepared to let us have serum samples from your haemophilia patients?" Read more about Professor Cash wrote to Dr Ludlam at the Royal Infirmary Edinburgh saying: "We (SNBTS) hope to have restricted access to the Chiron (NANB) testing kits and I write to enquire whether you would be prepared to let us have serum samples from your haemophilia patients?"
Professor Cash told the Penrose Inquiry that he very much regretted having been so tough on Dr Lloyd in regard to his unilaterally introducing anti-HCV testing. Read more about Professor Cash told the Penrose Inquiry that he very much regretted having been so tough on Dr Lloyd in regard to his unilaterally introducing anti-HCV testing.
Professor Cash told the Penrose Inquiry that he and Dr Gunson had fallen out badly over the postponement of routine screening for anti-HCV but they "fell in again" and he subsequently wrote a letter to Dr Gunson stating that the start date in September 1991 had the Scottish National Blood Transfusion Service directors' fullest support Read more about Professor Cash told the Penrose Inquiry that he and Dr Gunson had fallen out badly over the postponement of routine screening for anti-HCV but they "fell in again" and he subsequently wrote a letter to Dr Gunson stating that the start date in September 1991 had the Scottish National Blood Transfusion Service directors' fullest support
Professor Cash's evidence to the Penrose Inquiry was that Dr Gunson had told him at this time that funding issues in England were the source of the delay and that "this was a device to give the Department of Health more time, more space, to resolve these very difficult financial problems that they had." Read more about Professor Cash's evidence to the Penrose Inquiry was that Dr Gunson had told him at this time that funding issues in England were the source of the delay and that "this was a device to give the Department of Health more time, more space, to resolve these very difficult financial problems that they had."
In his evidence to the Penrose Inquiry, Dr Perry said he thought that the composition of the Advisory Committee on the Virological Safety of Blood was unduly biased to virology and that "the public health perspective was not as dominant...as it possibly could have been." His observation was that "the best became an enemy of the good" and that the search was for "perfect outcomes rather than good outcomes that could meet a public health need." Read more about In his evidence to the Penrose Inquiry, Dr Perry said he thought that the composition of the Advisory Committee on the Virological Safety of Blood was unduly biased to virology and that "the public health perspective was not as dominant...as it possibly could have been." His observation was that "the best became an enemy of the good" and that the search was for "perfect outcomes rather than good outcomes that could meet a public health need."
The submission on the Hepatitis C antibody screening test stated that it was unlikely routine screening could be introduced before 1 April 1991. The Minister was asked to agree that it should be introduced and that preparations should be made to introduce it "as soon as practicable." Read more about The submission on the Hepatitis C antibody screening test stated that it was unlikely routine screening could be introduced before 1 April 1991. The Minister was asked to agree that it should be introduced and that preparations should be made to introduce it "as soon as practicable."